alanine has been researched along with phenylephrine hydrochloride in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Brun, P; Constant, S; Dubois, J; Dulière, V; Errazuriz-Cerda, E; Fouret, J; Gaymard, A; Julien, T; Lescure, FX; Lina, B; Padey, B; Pizzorno, A; Poissy, J; Rosa-Calatrava, M; Terrier, O; Traversier, A; Trouillet-Assant, S; Yazdanpanah, Y | 1 |
| Ejima, K; Fujita, Y; Iwami, S; Iwanami, S; Kim, KS; Kuba, K; Miyazaki, T; Oda, T | 1 |
2 other study(ies) available for alanine and phenylephrine hydrochloride
| Article | Year |
|---|---|
Characterization and Treatment of SARS-CoV-2 in Nasal and Bronchial Human Airway Epithelia.
Topics: Adenosine Monophosphate; Airway Remodeling; Alanine; Animals; Antiviral Agents; Bronchi; Chlorocebus aethiops; COVID-19; COVID-19 Drug Treatment; Diltiazem; Drug Synergism; Humans; Immunity, Innate; Models, Biological; Nose; Respiratory Mucosa; SARS-CoV-2; Vero Cells | 2020 |
Incomplete antiviral treatment may induce longer durations of viral shedding during SARS-CoV-2 infection.
Topics: Adenosine Monophosphate; Alanine; Animals; Antiviral Agents; COVID-19; COVID-19 Drug Treatment; Lung; Macaca mulatta; Models, Theoretical; Nose; Pharynx; SARS-CoV-2; Time Factors; Viral Load; Virus Replication; Virus Shedding | 2021 |